Journal of Clinical Anesthesia
Journal of Clinical Anesthesia is a medical journal that focuses on anesthesia and related topics. It is a peer-reviewed journal that publishes original research, review articles, and clinical reports in all areas of anesthesia. The journal is published by Elsevier and the editor-in-chief is Paul G. Barash.
Overview[edit | edit source]
The Journal of Clinical Anesthesia (JCA) addresses all aspects of anesthesia practice, including anesthetic administration, pharmacokinetics, preoperative and postoperative considerations, coexisting disease and other complicating factors, cost issues, and similar concerns anesthesiologists contend with daily. Exceptionally high standards of presentation and clinically relevant literature are maintained.
History[edit | edit source]
The journal was established in 1989. The founding editor was Paul G. Barash, who is still the editor-in-chief. The journal is published by Elsevier, a leading provider of scientific, technical and medical information products and services.
Content[edit | edit source]
The content of the journal includes original research articles, review articles, and clinical reports. The topics covered include all aspects of anesthesia, including anesthetic administration, pharmacokinetics, preoperative and postoperative considerations, coexisting disease, and other complicating factors. The journal also covers cost issues and other concerns that anesthesiologists deal with on a daily basis.
Abstracting and indexing[edit | edit source]
The journal is abstracted and indexed in PubMed, Scopus, EMBASE, and the Science Citation Index. According to the Journal Citation Reports, the journal has a 2019 impact factor of 3.105.
See also[edit | edit source]
References[edit | edit source]
Journal of Clinical Anesthesia Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD